Загрузка...
Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib
Chronic myelomonocytic leukemia (CMML) is a heterogeneous neoplastic hematologic disorder with worse overall survival. Half of CMML have mutations, but case with concomitant mutations of DNA methyltransferase 3A (DNMT3A) and Internal tandem duplications of the juxtamembrane domain of FLT3 (FLT3-ITD)...
Сохранить в:
| Опубликовано в: : | Cancer Biol Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5710697/ https://ncbi.nlm.nih.gov/pubmed/28102729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2017.1281491 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|